J. Yamashita

M. Ogawa, J. Yamashita, N. Hayashi, 2005, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer.

M. Ogawa, J. Yamashita, Y. Kurusu, 1999, Surgery.

The sequence of vessel ligation affects tumor release into the circulation.

M. Ogawa, S. Mita, J. Yamashita, 1998, The Journal of thoracic and cardiovascular surgery.

High levels of hepatocyte growth factor/scatter factor in diffuse‐type bronchioloalveolar cell carcinoma

M. Ogawa, J. Yamashita, M. Abe, 1998, Cancer.

Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells.

M. Ogawa, J. Yamashita, S. Yamashita, 1993, Cancer research.

Analysis of estrogen receptors in human breast cancer by assays using monoclonal antibodies and by the dextran-coated charcoal method

J. Yamashita, K. Sakamoto, N. Fujino, 1987, The Japanese journal of surgery.

Tissue‐type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells

M. Ogawa, J. Yamashita, M. Kuramoto, 1995, Cancer.

Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl‐2 phosphorylation

M. Ogawa, J. Yamashita, M. Abe, 2000, Cancer.

Abundant expression of immunoreactive endothelin 1 in mammary phyllodes tumor: possible paracrine role of endothelin 1 in the growth of stromal cells in phyllodes tumor.

M. Ogawa, H. Egami, J. Yamashita, 1992, Cancer research.

Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines.

M. Ogawa, J. Yamashita, T. Beppu, 1993, Research communications in chemical pathology and pharmacology.

Plasma endothelin-1 and doxorubicin cardiotoxicity.

M. Ogawa, J. Yamashita, K. Nomura, 1994, The New England journal of medicine.

Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer.

M. Ogawa, J. Yamashita, S. Yamashita, 1994, Cancer research.

Endocrine Therapy in Pancreatic Carcinoma

M. Ogawa, J. Yamashita, M. Abe, 1998, Oncology.

Industrial preparation of poly(vinyl chloride).

M. Ogawa, J. Yamashita, I. Kawano, 1975, British Journal of Cancer.

Hormone control of total plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumours.

M. Ogawa, J. Yamashita, S. Yamashita, 1992, British Journal of Cancer.

Estrogen-dependent plasminogen activator in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in vivo and in vitro.

S. Horiuchi, J. Yamashita, N. Fujino, 1984, Gan.

Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues.

H. Egami, T. Kurizaki, J. Yamashita, 1996, British Journal of Cancer.

Hormonal regulation of plasminogen activator and peroxidase activities in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and the rat uterus

M. Ogawa, J. Yamashita, S. Yamashita, 1991, The Japanese journal of surgery.

Endothelin-1 is involved in the transient hypoparathyroidism seen in patients undergoing thyroid surgery.

M. Ogawa, J. Yamashita, K. Nomura, 1994, The Journal of endocrinology.

Breast cancer prognosis is poor when total plasminogen activator activity is low.

M. Ogawa, J. Yamashita, S. Yamashita, 1993, British Journal of Cancer.

Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats.

M. Ogawa, J. Yamashita, M. Toi, 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.

M. Ogawa, J. Yamashita, N. Hayashi, 2002, The Journal of thoracic and cardiovascular surgery.

Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer.

M. Ogawa, J. Yamashita, K. Sakai, 1995, Surgery.

Free‐form neutrophil elastase is an independent marker predicting recurrence in primary breast cancer

M. Ogawa, J. Yamashita, T. Shirakusa, 1995, Journal of leukocyte biology.

Placental plasminogen activator activity in pre‐eclampsia

J. Yamashita, T. Yoshimura, J. Yamashita, 1985, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency.

M. Ogawa, J. Yamashita, S. Yamashita, 1994, British Journal of Cancer.

Tamoxifen binding sites in human mammary cancers

J. Yamashita, K. Sakamoto, N. Fujino, 1986, The Japanese journal of surgery.

Carcinoma of the breast in a 6-year-old girl: a review of the Japanese literature

M. Ogawa, J. Yamashita, S. Yamashita, 1993, Pediatric Surgery International.

Platelet-derived endothelial cell growth factor/thymidine phosphorylase concentrations differ in small cell and non-small cell lung cancer.

M. Ogawa, J. Yamashita, M. Abe, 1999, Chest.

Neutrophil elastase inhibitor (ONO-5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice.

M. Ogawa, J. Yamashita, M Ogawa, 1997, Research communications in molecular pathology and pharmacology.

Tissue-type plasminogen activator is involved in skeletal metastasis from human breast cancer

M. Ogawa, J. Yamashita, S. Yamashita, 1992, International journal of clinical & laboratory research.

Plasma endothelin‐1 As a marker for doxorubicin cardiotoxicity

J. Yamashita, M Ogawa, T Shirakusa, 1995, International journal of cancer.

Increased expression of membrane‐associated phospholipase A2 shows malignant potential of human breast cancer cells

J. Yamashita, S. Yamashita, M. Ogawa, 1993, Cancer.

Elevation of serum group II phospholipase A2 levels in patients with advanced cancer.

J. Yamashita, M. Ogawa, S. Yamashita, 1994, Clinica chimica acta; international journal of clinical chemistry.

Group II phospholipase A2 in invasive gastric cancer cell line is induced by interleukin 6.

J. Yamashita, S. Yamashita, M. Ogawa, 1994, Biochemical and biophysical research communications.

INTER-SITE VARIATION OF HORMONE RECEPTORS IN PRIMARY HUMAN BREAST CANCERS

J. Yamashita, R. Nishimura, N. Fujino, 1982 .

Increased expression of membrane-associated phospholipase A2 in the lower respiratory tract of asymptomatic cigarette smokers.

M. Ogawa, J. Yamashita, T. Shirakusa, 1996, Respiratory medicine.

A large amount of endothelin-1 is present in human breast cancer tissues.

M. Ogawa, J. Yamashita, S. Yamashita, 1991, Research communications in chemical pathology and pharmacology.

Acute suppurative thyroiditis in an asymptomatic woman: an atypical presentation simulating thyroid carcinoma

M. Ogawa, J. Yamashita, S. Yamashita, 1994, Clinical endocrinology.

Clinical significance of circulating cancer cells in peripheral blood detected by reverse transcriptase-polymerase chain reaction in patients with breast cancer.

H. Egami, J. Yamashita, N. Hayashi, 2001, The Tohoku journal of experimental medicine.

Specific Stimulation by Estradiol of Tissue-Type Plasminogen Activator Production in 7,12-Dimethylbenz[a]Anthracene-Induced Rat Mammary Tumor Cells

M. Ogawa, J. Yamashita, S. Yamashita, 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Demonstration of a possible link between high grade malignancy in dimethylbenz[a]anthracene-induced rat mammary carcinoma and increased urokinase plasminogen activator content

M. Ogawa, J. Yamashita, S. Yamashita, 1992, International journal of clinical & laboratory research.

Sequential assays of hormone receptors and the tritiated thymidine labeling index in 7,12-dimethylbenz(a)anthracene-induced rat mammary cancers

J. Yamashita, R. Nishimura, K. Sakamoto, 1985, The Japanese journal of surgery.

Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of human lung.

M. Ogawa, H. Egami, J. Yamashita, 2003, Oncology reports.

Complete inhibition of spontaneous pulmonary metastasis of human lung carcinoma cell line EBC-1 by a neutrophil elastase inhibitor (ONO-5046.Na).

M. Ogawa, J. Yamashita, M Ogawa, 1998, Anticancer research.

Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues.

M. Ogawa, J. Yamashita, M. Toi, 2003, Oncology reports.

Cell biologic factors and cancer spread.

M. Ogawa, J. Yamashita, 1997, International journal of oncology.

Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of human lung

M. Ogawa, H. Egami, J. Yamashita, 2002 .

Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination.

M. Ogawa, J. Yamashita, N. Fujino, 2000, The Journal of thoracic and cardiovascular surgery.

Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.

M. Ogawa, H. Sato, J. Yamashita, 1994, British Journal of Cancer.

M. Ogawa, J. Yamashita, N. Hayashi, 2002, The Journal of thoracic and cardiovascular surgery.